Singapore: Eisai launched NerBloc Intramuscular Injection 2500 Units (botulinum toxin type B, "NerBloc"), a neuromuscula...
Singapore: Wyss Institute for Biologically Inspired Engineering at Harvard University has collaborated with Sony DADC, d...
Singapore: Takeda Pharmaceutical has submitted a new drug application (NDA) to the Japanese Ministry of Health, Labour a...
Singapore: Japan-based Ono Pharmaceuticals recently announced that the company has entered into an agreement with Gilead...
Singapore:Â Sanofi has been ranked third among 20 pharmaceutical companies on the 2012 Access to Medicine Index (ATM I...
Singapore: Akebia Therapeutics and Mitsubishi Tanabe Pharma Corporation (MTPC)has announced that they have entered into ...
There is a fear that avian H5N1 virus could cause a pandemic of new influenza in humans without any warning. To prevent ...
Tokyo: Shionogi, one of Japan's century-old pharmaceutical manufacturers, has announced that its once-daily naldemedine ...
Tokyo: Japan's Asahi Kasei Chemicals and US-based SPI Pharma Inc. have agreed to form an alliance in the field of pharma...
Singapore: Aerocrine AB, a Swedish medical products company, has launched its marketing and sales efforts of Aerocrine's...
Singapore: The ministry of Health, Labor and Welfare (MHLW) in Japan has approved a drug for the treatment of patients w...
Singapore: The US FDA has recently given its approval for a device that treats dialysis-related amyloidosis (DRA), a com...
Singapore:Â Eisai announced that the US FDA has granted orphan drug designation to its investigational drug lenvatinib...
Singapore: Pluristem Therapeutics, an Israel-based developer of placenta-based cell therapy products, has announced that...
Singapore: Taconic Biosciences, a global leading provider of genetically modified animal models to researchers, recently...
Singapore: Zecotek Photonics, a developer of leading-edge photonics technologies for medical, industrial and scientific ...
Singapore: AstraZeneca has partnered with Japan-based Daiichi Sankyo to co-commercialize Movantik (naloxegol) in the US,...
Singapore: Japanese pharmaceutical major Astellas Pharma has announced that it would cut down its group workforce in hom...
Singapore: Research & Diagnostic Antibodies (R&D Antibodies) received a notice of allowance from the Japan Paten...
Singapore: Takeda Pharmaceutical has achieved positive reponse from its phase I/II study of its intramuscular bivalent (...
Singapore: US-based Targeted Medical Pharma has signed an exclusive product distribution agreement with J-Network, a Cal...
Singapore:Â Dainippon Sumitomo Pharma (DSP) has signed a research, development and commercial license agreement for th...
CryoLife Inc., a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced...
Singapore: The world's most powerful microscope, which resides in a specially constructed room at the University of Vict...
Singapore: Sosei Group Corporation, a leading Japanese biopharmaceutical company with operations in Japan and the UK, ha...
